These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31970031)

  • 1. Comparing the Efficacy and Safety of Denosumab with Bisphosphonates in Increasing Bone Mineral Density in Patients with Prostate Cancer and Breast Cancer on Antihormonal Treatment.
    Razaq A; Khan S; Hassan J; Malik BH; Razaq M
    Cureus; 2019 Dec; 11(12):e6401. PubMed ID: 31970031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventing Osteoporosis in Men Taking Androgen Deprivation Therapy for Prostate Cancer: A Systematic Review and Meta-Analysis.
    Joseph JS; Lam V; Patel MI
    Eur Urol Oncol; 2019 Sep; 2(5):551-561. PubMed ID: 31411986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of cancer treatment-induced bone loss (CTIBL) in patients with breast cancer or prostate cancer.
    Takahashi S
    J Bone Miner Metab; 2023 May; 41(3):307-316. PubMed ID: 37036530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonates and other bone agents for breast cancer.
    Wong MH; Stockler MR; Pavlakis N
    Cochrane Database Syst Rev; 2012 Feb; (2):CD003474. PubMed ID: 22336790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials.
    Galvano A; Scaturro D; Badalamenti G; Incorvaia L; Rizzo S; Castellana L; Cusenza S; Cutaia S; Santini D; Guadagni F; Roselli M; Gori S; Latteri MA; Bazan V; Giulia LM; Russo A
    J Bone Oncol; 2019 Oct; 18():100252. PubMed ID: 31440444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [On "2015 Guidelines for Prevention and Treatment of Osteoporosis". Osteoporosis associated with sex hormone depletion treatment].
    Takahashi S
    Clin Calcium; 2015 Sep; 25(9):1357-65. PubMed ID: 26320536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Denosumab is really effective in the treatment of osteoporosis secondary to hypogonadism in prostate carcinoma patients? A prospective randomized multicenter international study.
    Doria C; Leali PT; Solla F; Maestretti G; Balsano M; Scarpa RM
    Clin Cases Miner Bone Metab; 2016; 13(3):195-199. PubMed ID: 28228781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis.
    Wu J; Zhang Q; Yan G; Jin X
    J Orthop Surg Res; 2018 Aug; 13(1):194. PubMed ID: 30071889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphonates for osteoporosis in nonmetastatic prostate cancer patients receiving androgen-deprivation therapy: a systematic review and meta-analysis.
    Ding H; Yang L; Du W; Teng Y; Fu SJ; Tao Y; Lu JZ; Wang ZP
    Asian Pac J Cancer Prev; 2013; 14(5):3337-43. PubMed ID: 23803126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial.
    Gnant M; Pfeiler G; Dubsky PC; Hubalek M; Greil R; Jakesz R; Wette V; Balic M; Haslbauer F; Melbinger E; Bjelic-Radisic V; Artner-Matuschek S; Fitzal F; Marth C; Sevelda P; Mlineritsch B; Steger GG; Manfreda D; Exner R; Egle D; Bergh J; Kainberger F; Talbot S; Warner D; Fesl C; Singer CF;
    Lancet; 2015 Aug; 386(9992):433-43. PubMed ID: 26040499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Denosumab compared to other treatments to prevent or treat osteoporosis in individuals at risk of fracture: a systematic review and meta-analysis.
    Beaudoin C; Jean S; Bessette L; Ste-Marie LG; Moore L; Brown JP
    Osteoporos Int; 2016 Sep; 27(9):2835-2844. PubMed ID: 27120345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment-induced bone loss and fractures in cancer patients undergoing hormone ablation therapy: efficacy and safety of denosumab.
    Lipton A; Smith MR; Ellis GK; Goessl C
    Clin Med Insights Oncol; 2012; 6():287-303. PubMed ID: 22933844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive review of denosumab for bone metastasis in patients with solid tumors.
    Gül G; Sendur MA; Aksoy S; Sever AR; Altundag K
    Curr Med Res Opin; 2016; 32(1):133-45. PubMed ID: 26451465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review on the comparison of effectiveness between denosumab and bisphosphonates in post-menopausal osteoporosis.
    Benjamin B; Benjamin MA; Swe M; Sugathan S
    Osteoporos Sarcopenia; 2016 Jun; 2(2):77-81. PubMed ID: 30775470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Denosumab in osteoporosis and oncology.
    Burkiewicz JS; Scarpace SL; Bruce SP
    Ann Pharmacother; 2009 Sep; 43(9):1445-55. PubMed ID: 19622756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of osteoporosis secondary to hypogonadism in prostate cancer patients: a prospective randomized multicenter international study with denosumab vs. alendronate.
    Doria C; Mosele GR; Solla F; Maestretti G; Balsano M; Scarpa RM
    Minerva Urol Nefrol; 2017 Jun; 69(3):271-277. PubMed ID: 27813398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Bone Turnover / Quality Markers and Bone Mineral Density in Prostate Cancer Patients Receiving Androgen Deprivation Therapy with or without Denosumab.
    Miyazawa Y; Sekine Y; Syuto T; Nomura M; Koike H; Matsui H; Shibata Y; Ito K; Suzuki K
    Anticancer Res; 2017 Jul; 37(7):3667-3671. PubMed ID: 28668858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Denosumab in osteoporosis.
    Diab DL; Watts NB
    Expert Opin Drug Saf; 2014 Feb; 13(2):247-53. PubMed ID: 24289327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 24-month study evaluating the efficacy and safety of denosumab for the treatment of men with low bone mineral density: results from the ADAMO trial.
    Langdahl BL; Teglbjærg CS; Ho PR; Chapurlat R; Czerwinski E; Kendler DL; Reginster JY; Kivitz A; Lewiecki EM; Miller PD; Bolognese MA; McClung MR; Bone HG; Ljunggren Ö; Abrahamsen B; Gruntmanis U; Yang YC; Wagman RB; Mirza F; Siddhanti S; Orwoll E
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1335-42. PubMed ID: 25607608
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.